Issued Patents All Time
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12365688 | Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors | Brian R. BLANK, Jennifer Pitzen, Gang Wang, Walter Won, Christos TZITZILONIS +8 more | 2025-07-22 |
| 12187746 | C26-linked rapamycin analogs as mTOR inhibitors | Christopher Semko, Gang Wang, G. Leslie Burnett, James Aggen, James Cregg +6 more | 2025-01-07 |
| 11739093 | Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors | Brian R. BLANK, Jennifer Pitzen, Gang Wang, Walter Won, Christos TZITZILONIS +8 more | 2023-08-29 |
| 11685749 | C26-linked rapamycin analogs as mTOR inhibitors | Christopher Semko, Gang Wang, G. Leslie Burnett, James Aggen, James Cregg +6 more | 2023-06-27 |
| 11673896 | Pyridine compounds as allosteric SHP2 inhibitors | Adrian Liam Gill, Naing Aay, Kevin T. Mellem, Andreas BUCKL, Elena S. Koltun +1 more | 2023-06-13 |
| 11661401 | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors | Elena S. Koltun, Kevin T. Mellem, Adrian Liam Gill, Christopher Semko, Naing Aay +3 more | 2023-05-30 |
| 10980889 | C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors | Jennifer Pitzen, Micah James Gliedt, G. Leslie Burnett, James Aggen, Christopher Semko +6 more | 2021-04-20 |
| 10590090 | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors | Elena S. Koltun, Kevin T. Mellem, Adrian Liam Gill, Christopher Semko, Naing Aay +3 more | 2020-03-17 |